Opinion: Tackling drug shortages with data, AI, legislation, and more
Every quarter since 2014, roughly 150 to 300 drugs have been in short supply in the U.S. The drug shortages list has included injectable morphine and other painkillers, anesthetics, antibiotics, cancer drugs, medications for mental illness, and much more.
In June 2018, a bipartisan group of 31 U.S. senators and 104 members of the House of Representatives wrote to then-FDA Commissioner Scott Gottlieb in hopes of addressing the nation’s drug shortage crisis. The Food and Drug Administration’s analyses had shown that the number of ongoing drug shortages was increasing, some lasting longer than eight years. Later analysis done by the FDA in early 2020 found that while there have been incremental improvements, drug shortages continue to be an ongoing issue.
Read Original Article: Opinion: Tackling drug shortages with data, AI, legislation, and more »
